What are the recommended dosing, contraindications, and precautions for temazepam in adults?

Temazepam for Chronic Insomnia in Adults

Temazepam 15 mg taken at bedtime is the recommended starting dose for most adults with chronic insomnia, specifically targeting sleep onset and sleep maintenance problems. 1, 2

Recommended Dosing

Standard Adult Dosing:

• Initial dose: 15 mg at bedtime for most adults 1, 2
• Lower dose: 7.5 mg may be sufficient for some patients, particularly for transient insomnia where improving sleep latency is the primary goal 2, 3
• Maximum dose: 30 mg for patients requiring higher doses 2

Elderly or Debilitated Patients:

• Start with 7.5 mg and titrate based on individual response 2
• This population has substantially increased risk of oversedation, dizziness, confusion, and ataxia with higher doses 2

The American Academy of Sleep Medicine (2017) provides a WEAK recommendation for temazepam use, meaning clinicians should use clinical judgment and patient preferences, though the majority of patients would choose this treatment over no treatment 1.

Clinical Efficacy

Temazepam demonstrates effectiveness for:

• Sleep onset insomnia - reduces subjective sleep latency beyond clinically significant thresholds 1
• Sleep maintenance insomnia - improves total sleep time and reduces wake after sleep onset 1
• Sleep efficiency - increases both subjective and objective measures 1

The evidence base consists of moderate-quality data from randomized controlled trials, with the 15 mg dose having the strongest supporting evidence 1, 4.

Contraindications

Absolute contraindications:

• Known hypersensitivity to benzodiazepines
• History of angioedema with sedative-hypnotics 2
• Pregnancy (particularly when combined with diphenhydramine - one case of stillbirth reported) 2

Critical Precautions and Warnings

High-Priority Safety Concerns

Concomitant Opioid Use:

• Risk of fatal respiratory depression and profound sedation 2
• Avoid combination unless absolutely necessary and under close supervision
• If combined, patients must not drive or operate machinery 2

Abuse, Dependence, and Withdrawal:

• Temazepam carries risks of abuse, misuse, and addiction even at recommended doses 2
• Physical dependence develops with continued use
• Abrupt discontinuation can precipitate life-threatening withdrawal reactions 2
• Use gradual taper for discontinuation - if withdrawal symptoms emerge, pause taper or increase to previous dose level, then decrease more slowly 2
• Protracted withdrawal syndrome can last weeks to over 12 months in some cases 2

Complex Sleep Behaviors:

• "Sleep-driving" and other complex behaviors (eating, phone calls, sexual activity) can occur with amnesia for the event 2
• Risk increases with alcohol or other CNS depressants, and with doses exceeding recommendations 2
• Strongly consider discontinuation if sleep-driving episode occurs 2

Anaphylaxis:

• Rare but potentially fatal angioedema involving tongue, glottis, or larynx 2
• Can occur after first or subsequent doses
• Never rechallenge patients who develop angioedema 2

Population-Specific Precautions

Elderly Patients:

• Increased fall risk due to drowsiness and decreased consciousness 2
• Higher risk of oversedation, confusion, and ataxia 2
• Must start at 7.5 mg 2

Depression:

• Use with caution in severely depressed patients 2
• Worsening depression and suicidal thinking reported with sedative-hypnotics 2
• Recognize suicidal tendencies may be present; protective measures necessary 2

Organ Dysfunction:

• Exercise caution in impaired renal or hepatic function 2
• Use caution in chronic pulmonary insufficiency 2

Drug Interactions:

• Avoid alcohol and other CNS depressants - synergistic effects increase risk of complex behaviors and respiratory depression 2
• Specific synergistic effect documented with diphenhydramine 2
• Consider additive effects when combining with any hypnotic or CNS-depressant medication 2

Pharmacokinetic Considerations

• Peak plasma concentration: 3 hours after oral ingestion 5
• Half-life: 10-15 hours (longer in elderly) 5, 6
• No clinically significant active metabolites 5, 6
• Absorbed more slowly than other benzodiazepines, which may explain limited effect on sleep onset in some studies 5

Comparative Context

While temazepam is effective, the evidence quality is low to very low with benefits outweighing harms 1. Observational data links benzodiazepines (particularly those with half-lives >24 hours) to dementia risk, though temazepam's intermediate half-life places it in a lower-risk category 4. The 2017 AASM guideline places temazepam among several acceptable options including non-benzodiazepine receptor agonists (zolpidem, eszopiclone) and other agents, with choice depending on specific sleep complaints and patient factors 1.

Common Pitfalls to Avoid

1. Starting elderly patients at standard 15 mg dose - always begin at 7.5 mg 2
2. Abrupt discontinuation - always use gradual taper to prevent withdrawal 2
3. Combining with opioids without careful consideration - high risk of fatal respiratory depression 2
4. Continuing medication after sleep-driving episode - strongly consider discontinuation 2
5. Long-term continuous use for chronic idiopathic insomnia - not generally accepted practice 7
6. Ignoring fall risk in elderly - counsel patients about increased risk 2